Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2026-03-07 @ 10:56 PM
Study NCT ID:
NCT01148134
Status:
TERMINATED
Last Update Posted:
2013-01-11
First Post:
2010-06-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
10-0300-CE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None